These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12714025)

  • 1. Framingham risk function overestimates risk of coronary heart disease in men and women from Germany--results from the MONICA Augsburg and the PROCAM cohorts.
    Hense HW; Schulte H; Löwel H; Assmann G; Keil U
    Eur Heart J; 2003 May; 24(10):937-45. PubMed ID: 12714025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study.
    Empana JP; Ducimetière P; Arveiler D; Ferrières J; Evans A; Ruidavets JB; Haas B; Yarnell J; Bingham A; Amouyel P; Dallongeville J;
    Eur Heart J; 2003 Nov; 24(21):1903-11. PubMed ID: 14585248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study.
    Liu J; Hong Y; D'Agostino RB; Wu Z; Wang W; Sun J; Wilson PW; Kannel WB; Zhao D
    JAMA; 2004 Jun; 291(21):2591-9. PubMed ID: 15173150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation.
    Ferrario M; Chiodini P; Chambless LE; Cesana G; Vanuzzo D; Panico S; Sega R; Pilotto L; Palmieri L; Giampaoli S;
    Int J Epidemiol; 2005 Apr; 34(2):413-21. PubMed ID: 15659467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classical risk factors and their impact on incident non-fatal and fatal myocardial infarction and all-cause mortality in southern Germany. Results from the MONICA Augsburg cohort study 1984-1992. Monitoring Trends and Determinants in Cardiovascular Diseases.
    Keil U; Liese AD; Hense HW; Filipiak B; Döring A; Stieber J; Löwel H
    Eur Heart J; 1998 Aug; 19(8):1197-207. PubMed ID: 9740341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men.
    Haq IU; Ramsay LE; Yeo WW; Jackson PR; Wallis EJ
    Heart; 1999 Jan; 81(1):40-6. PubMed ID: 10220543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study.
    Brindle P; Emberson J; Lampe F; Walker M; Whincup P; Fahey T; Ebrahim S
    BMJ; 2003 Nov; 327(7426):1267. PubMed ID: 14644971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applicability of Framingham risk equations for studying a low-income Mexican population.
    Jiménez-Corona A; López-Ridaura R; Williams K; González-Villalpando ME; Simón J; González-Villalpando C
    Salud Publica Mex; 2009; 51(4):298-305. PubMed ID: 19668924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive accuracy of original and recalibrated Framingham risk score in the Swiss population.
    Marques-Vidal P; Rodondi N; Bochud M; Chiolero A; Pécoud A; Hayoz D; Paccaud F; Mooser V; Firmann M; Waeber G; Vollenweider P
    Int J Cardiol; 2009 Apr; 133(3):346-53. PubMed ID: 18485502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany.
    Koenig W; Löwel H; Baumert J; Meisinger C
    Circulation; 2004 Mar; 109(11):1349-53. PubMed ID: 15023871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How generalizable are coronary risk prediction models? Comparison of Framingham and two national cohorts.
    Liao Y; McGee DL; Cooper RS; Sutkowski MB
    Am Heart J; 1999 May; 137(5):837-45. PubMed ID: 10220632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary heart disease risk assessment in diabetes mellitus--a comparison of PROCAM and Framingham risk assessment functions.
    Game FL; Jones AF
    Diabet Med; 2001 May; 18(5):355-9. PubMed ID: 11472444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity of the Framingham point scores in the elderly: results from the Rotterdam study.
    Koller MT; Steyerberg EW; Wolbers M; Stijnen T; Bucher HC; Hunink MG; Witteman JC
    Am Heart J; 2007 Jul; 154(1):87-93. PubMed ID: 17584559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas.
    Marrugat J; D'Agostino R; Sullivan L; Elosua R; Wilson P; Ordovas J; Solanas P; Cordón F; Ramos R; Sala J; Masiá R; Kannel WB
    J Epidemiol Community Health; 2003 Aug; 57(8):634-8. PubMed ID: 12883073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a scoring scheme, including proinsulin and the apolipoprotein B/apolipoprotein A1 ratio, for the risk of acute coronary events in middle-aged men: Uppsala Longitudinal Study of Adult Men (ULSAM).
    Dunder K; Lind L; Zethelius B; Berglund L; Lithell H
    Am Heart J; 2004 Oct; 148(4):596-601. PubMed ID: 15459588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting coronary heart disease risk using the Framingham and PROCAM equations in dyslipidaemic patients without overt vascular disease.
    Vrentzos GE; Papadakis JA; Ganotakis ES; Paraskevas KI; Gazi IF; Tzanakis N; Nair DR; Mikhailidis DP
    Int J Clin Pract; 2007 Oct; 61(10):1643-53. PubMed ID: 17877651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of Framingham and SCORE-based cardiovascular risk estimates in participants of the German National Health Interview and Examination Survey 1998.
    Neuhauser HK; Ellert U; Kurth BM
    Eur J Cardiovasc Prev Rehabil; 2005 Oct; 12(5):442-50. PubMed ID: 16210930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-reactive protein, depressed mood, and the prediction of coronary heart disease in initially healthy men: results from the MONICA-KORA Augsburg Cohort Study 1984-1998.
    Ladwig KH; Marten-Mittag B; Löwel H; Döring A; Koenig W;
    Eur Heart J; 2005 Dec; 26(23):2537-42. PubMed ID: 16126719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of a Protein-Based Risk Score for Cardiovascular Outcomes Among Patients With Stable Coronary Heart Disease.
    Ganz P; Heidecker B; Hveem K; Jonasson C; Kato S; Segal MR; Sterling DG; Williams SA
    JAMA; 2016 Jun; 315(23):2532-41. PubMed ID: 27327800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of apolipoprotein B and A-I in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA/KORA Augsburg cohort study.
    Meisinger C; Loewel H; Mraz W; Koenig W
    Eur Heart J; 2005 Feb; 26(3):271-8. PubMed ID: 15618061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.